Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Brain region vulnerable to aging is larger in those with longevity gene variant

  • Things smell good for a reason

  • That's using your head: Brain regulates fat metabolism, potentially stopping disease

  • How creative are you? Depends where you're from

  • Drug candidates can block pathway associated with cell death in Parkinson's disease

  • MRIs link impaired brain activity to inability to regulate emotions in autism

  • Decisions on Future Childbearing in Women Diagnosed with a Meningioma

  • Age concern in largest ever study of heroin user deaths

  • Researchers find potential anti-cancer use for anti-epilepsy drug

  • Association between parental time pressure, mental health problems among children

  •